Log In
Print
BCIQ
Print
Print this Print this
 

SL-401

  Manage Alerts
Collapse Summary General Information
Company Stemline Therapeutics Inc.
DescriptionIL-3 receptor targeting agent linked to a truncated diphtheria toxin payload
Molecular Target Interleukin-3 (IL-3) receptor
Mechanism of Action 
Therapeutic ModalityBiologic: Fusion protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today